About
Overview
Our Team
Board of Directors
Scientific Advisory Board
Contact
Science
PAM Pathway
Publications
Pipeline
Overview
Gedatolisib
Expanded Access
Clinical Trials
VIKTORIA-1: Breast Cancer
VIKTORIA-2: Breast Cancer
CELC-G-201: Prostate Cancer
Investors
Investors
Press Releases
Events & Presentations
Stock Information
SEC Filings
Corporate Governance
Analyst Coverage
IR Resources
Careers
Overview
Culture & Benefits
Open Positions
Investor Relations
Investor Home
Press Releases
Events & Presentations
Stock Information
SEC Filings
Corporate Governance
Analyst Coverage
IR Alerts
Privacy Policy
Stock Quote
NASDAQ CM: CELC
$12.50
Oct 28, 2025 4:00 PM EDT
Change
-0.5 (-3.85%)
Volume
57,919
Today’s Open
$12.93
Previous Close
$13.00
Today’s High
$13.27
Today’s Low
$12.31
52 Week High
$63.00
52 Week Low
$9.81
Stock Chart